CVS Health announced this week that it has extended the access of naloxone, its opioid overdose-reversal medication, in its CVS Pharmacy locations to include eight additional states.
These states include Connecticut, Kentucky, Maryland, North Carolina, New Hampshire, Ohio, Virginia and Vermont. Naloxene will be available in these eight states by the end of March.
As stated in a physician-approved protocol permitted by each of these states, CVS Pharmacy will be allowed to sell naloxone in the states to customers without requiring them to have an individual prescription. By expanding access of naloxone, which has been proven to be safe and effective, CVS Health hopes to save lives and provide people with the opportunity to get the help they need. The new protocol put in place will help CVS Health stay true to its commitment to help stop drug abuse.
Naloxene is already available at CVS Pharmacy locations in Arkansas, California, Indiana, Massachusetts, Minnesota, Mississippi, Montana, New Jersey, New York, North Dakota, Pennsylvania, Rhode Island, Tennessee, Utah and Wisconsin through a standing order or practice agreements.